Real world effectiveness of jak inhibitor upadacitinib in ulcerative colitis versus crohn ’s disease in an ibd tertiary care center.

Upadacitinib is a selective Janus kinase inhibitor approved for the management of Crohn ’s Disease (CD) and Ulcerative Colitis (UC).

Source: Gastroenterology - January 25, 2024 Category: Gastroenterology Authors: Karan Bhatia, Uma Mahadevan Source Type: research